Related Experiment Video
Updated: Aug 26, 2025

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Invasive Bordetella pertussis Infection in Infants: A Case Report
Yang Liao1,2, Wei-Ran Li1,2, Yu Zhu1,2
1Department of Infection, West China Second Hospital affiliated with Sichuan University, Chengdu, China.
Insights
Infants are susceptible to severe pertussis. This case highlights a severe pertussis infection in a 2-month-old infant, involving respiratory failure, pneumonia, septic shock, and encephalopathy.
Area of Science:
- Pediatrics
- Infectious Diseases
- Microbiology
Background:
- Infants face a higher risk of severe pertussis.
- Pertussis, caused by *Bordetella pertussis*, can lead to critical illness in early life.
Purpose of the Study:
- To report a rare case of malignant pertussis in an infant.
- To illustrate the diagnostic methods used for severe pertussis.
Main Methods:
- Clinical case presentation of a 2-month-old infant with severe symptoms.
- Detection of *Bordetella pertussis* using polymerase chain reaction (PCR) on nasopharyngeal secretions.
- Metagenomics next-generation sequencing (mNGS) applied to blood and cerebrospinal fluid (CSF) samples.
Main Results:
- The infant presented with respiratory failure, severe pneumonia, septic shock, and encephalopathy.
- *Bordetella pertussis* was identified in nasopharyngeal, blood, and CSF samples.
- Diagnostic confirmation through both PCR and mNGS.
Conclusions:
- Malignant pertussis is a life-threatening condition in infants.
- Advanced molecular techniques like mNGS are valuable for diagnosing severe pertussis, even in blood and CSF.
- Early recognition and diagnosis are crucial for managing severe pertussis in infants.
Abstract:
Infants are more likely to develop severe pertussis. We report a malignant pertussis case in a 2-month-old boy with respiratory failure, severe pneumonia, septic shock, and encephalopathy. Bordetella pertussis was detected from nasopharyngeal secretions by polymerase chain reaction, as well as both blood and cerebrospinal fluid samples via metagenomics next-generation sequencing.
Related Concept Videos
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pulmonary Cycle: Exhalation
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pneumonia III: Complications and Assessment
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

